Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Nat Neurosci ; 11(6): 649-58, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18382462

ABSTRACT

The mechanisms that regulate the pruning of mammalian axons are just now being elucidated. Here, we describe a mechanism by which, during developmental sympathetic axon competition, winning axons secrete brain-derived neurotrophic factor (BDNF) in an activity-dependent fashion, which binds to the p75 neurotrophin receptor (p75NTR) on losing axons to cause their degeneration and, ultimately, axon pruning. Specifically, we found that pruning of rat and mouse sympathetic axons that project to the eye requires both activity-dependent BDNF and p75NTR. p75NTR and BDNF are also essential for activity-dependent axon pruning in culture, where they mediate pruning by directly causing axon degeneration. p75NTR, which is enriched in losing axons, causes axonal degeneration by suppressing TrkA-mediated signaling that is essential for axonal maintenance. These data provide a mechanism that explains how active axons can eliminate less-active, competing axons during developmental pruning by directly promoting p75NTR-mediated axonal degeneration.


Subject(s)
Axons/physiology , Brain-Derived Neurotrophic Factor/physiology , Nerve Degeneration/physiopathology , Receptor, Nerve Growth Factor/physiology , Animals , Animals, Newborn , Axons/drug effects , Axotomy/methods , Brain-Derived Neurotrophic Factor/pharmacology , Cells, Cultured , Cholera Toxin/metabolism , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/physiology , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Degeneration/drug therapy , Nerve Degeneration/genetics , Nerve Growth Factor/pharmacology , Neurons/cytology , Potassium Chloride/pharmacology , Rats , Rats, Sprague-Dawley , Receptor, Nerve Growth Factor/deficiency , Stilbamidines/metabolism , Superior Cervical Ganglion/cytology , Superior Cervical Ganglion/growth & development , Visual Pathways/growth & development , Visual Pathways/metabolism
2.
J Neurosci ; 26(51): 13344-56, 2006 Dec 20.
Article in English | MEDLINE | ID: mdl-17182785

ABSTRACT

Multiple cues, including growth factors and circuit activity, signal to regulate the initiation and growth of mammalian dendrites. In this study, we have asked how these environmental cues regulate dendrite formation, and in particular, whether dendrite initiation and growth requires integrin-linked kinase (ILK) or its downstream effector, glycogen synthase kinase-3beta (GSK-3beta). In cultured sympathetic neurons, NGF and neuronal depolarization activated ILK and promoted dendrite initiation and growth, and inhibition of ILK (either pharmacologically, with a dominant-negative form of ILK, or by genetic knockdown) reduced depolarization-induced dendrite formation. In sympathetic neurons, ILK phosphorylated and inhibited GSK-3beta, and inhibition of GSK-3beta (either pharmacologically, with dominant-negative GSK-3beta, or by genetic knockdown) caused robust dendrite initiation. GSK-3beta inhibition also caused dendrite initiation in cultured cortical neurons and growth of hippocampal neurons in slice cultures. GSK-3beta functioned downstream of ILK to regulate dendrite formation, because inhibition of GSK-3beta promoted dendrite initiation even when ILK was simultaneously inhibited. Moreover, GSK-3beta promoted dendrite formation in sympathetic neurons by regulating the activity of a key dendrite formation effector, the MAP (microtubule-associated protein) kinase kinase (MEK)-extracellular signal-regulated protein kinase (ERK) pathway. Specifically, inhibition of GSK-3beta led to increased ERK phosphorylation, and inhibition of MEK completely blocked the effects of GSK-3beta inhibition on dendrite initiation and growth. Thus, the ILK-GSK-3beta pathway plays a key role in regulating dendrite formation in developing mammalian neurons.


Subject(s)
Cell Enlargement , Dendrites/enzymology , Glycogen Synthase Kinase 3/physiology , Protein Serine-Threonine Kinases/physiology , Signal Transduction/physiology , Animals , Animals, Newborn , Cells, Cultured , Glycogen Synthase Kinase 3 beta , Hippocampus/cytology , Hippocampus/enzymology , Hippocampus/growth & development , Rats , Rats, Sprague-Dawley
3.
J Cereb Blood Flow Metab ; 34(2): 357-66, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24301295

ABSTRACT

White matter sparing after traumatic brain injury (TBI) is an important predictor of survival and outcome. Blood vessels and axons are intimately associated anatomically and developmentally. Neural input is required for appropriate vascular patterning, and vascular signaling is important for neuron development and axon growth. Owing to this codependence between endothelial cells and axons during development and the contribution of endothelial progenitor cells (EPCs) in ischemic injury, we hypothesized that EPCs are important in axonal survival after TBI. We examined the effects of allogenic-cultured EPCs on white matter protection and microvascular maintenance after midline fluid percussion injury in adult Sprague-Dawley rats. We used two in vitro models of injury, mechanical stretch and oxygen-glucose deprivation (OGD), to examine the effects of EPCs on the mechanical and ischemic components of brain trauma, respectively. Our results indicate that EPCs improve the white matter integrity and decrease capillary breakdown after injury. Cultured cortical neurons exposed to OGD had less axon degeneration when treated with EPC-conditioned media, whereas no effect was seen in axons injured by mechanical stretch. The results indicate that EPCs are important for the protection of the white matter after trauma and represent a potential avenue for therapy.


Subject(s)
Axons , Bone Marrow Cells/metabolism , Brain Injuries , Brain Ischemia , Endothelial Cells , Stem Cell Transplantation , Stem Cells/metabolism , Allografts , Animals , Axons/metabolism , Axons/pathology , Brain Injuries/metabolism , Brain Injuries/pathology , Brain Injuries/physiopathology , Brain Injuries/therapy , Brain Ischemia/metabolism , Brain Ischemia/pathology , Brain Ischemia/physiopathology , Brain Ischemia/therapy , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Disease Models, Animal , Endothelial Cells/metabolism , Endothelial Cells/transplantation , Male , Rats , Rats, Sprague-Dawley
4.
Nat Neurosci ; 13(5): 559-66, 2010 May.
Article in English | MEDLINE | ID: mdl-20348920

ABSTRACT

Axonal degeneration is important during development but has not been thought to function in the intact mature nervous system. Here, we provide evidence that degeneration of adult axons occurs in the intact rodent brain through a p75 neurotrophin receptor (p75NTR)- and myelin-dependent mechanism. Specifically, we show that p75NTR-mediated axonal degeneration prevents septal cholinergic axons from aberrantly growing onto myelinated tracts in vivo or on a myelin substrate in culture. Myelin also triggers local degeneration of p75NTR-expressing sympathetic axons that is rescued by increasing TrkA signaling or elevating intracellular cyclic AMP. Myelin-mediated degeneration occurs when neurotrophins bind to p75NTR, and involves p75NTR-dependent sequestration of Rho guanine nucleotide dissociation inhibitor (Rho-GDI). Moreover, degeneration, but not growth inhibition, requires downstream activation of Rho and caspase-6. These data indicate that p75NTR maintains the specificity of neural connectivity by preventing inappropriate sprouting onto myelinated tracts and provide a physiological explanation for myelin inhibition after neural injury.


Subject(s)
Axons/physiology , Myelin Sheath/metabolism , Nerve Degeneration/metabolism , Nerve Degeneration/pathology , Receptor, Nerve Growth Factor/metabolism , Animals , Caspase 6/metabolism , Cells, Cultured , Choline O-Acetyltransferase/metabolism , Cofilin 1/metabolism , Cyclic AMP/metabolism , Dose-Response Relationship, Drug , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Green Fluorescent Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Nerve Growth Factor/pharmacology , Nerve Growth Factors/metabolism , Neurons/physiology , Protein Transport/drug effects , Rats , Rats, Sprague-Dawley , Receptor, Nerve Growth Factor/genetics , Receptor, trkA/metabolism , Septum of Brain/cytology , Signal Transduction/drug effects , Signal Transduction/genetics , Spinal Cord/metabolism , Time Factors , Tubulin/metabolism , rho GTP-Binding Proteins/metabolism
5.
PLoS One ; 4(8): e6810, 2009 Aug 27.
Article in English | MEDLINE | ID: mdl-19710912

ABSTRACT

BACKGROUND: Rett Syndrome (RTT) is an Autism Spectrum Disorder and the leading cause of mental retardation in females. RTT is caused by mutations in the Methyl CpG-Binding Protein-2 (MECP2) gene and has no treatment. Our objective is to develop viral vectors for MECP2 gene transfer into Neural Stem Cells (NSC) and neurons suitable for gene therapy of Rett Syndrome. METHODOLOGY/PRINCIPAL FINDINGS: We generated self-inactivating (SIN) retroviral vectors with the ubiquitous EF1alpha promoter avoiding known silencer elements to escape stem-cell-specific viral silencing. High efficiency NSC infection resulted in long-term EGFP expression in transduced NSC and after differentiation into neurons. Infection with Myc-tagged MECP2-isoform-specific (E1 and E2) vectors directed MeCP2 to heterochromatin of transduced NSC and neurons. In contrast, vectors with an internal mouse Mecp2 promoter (MeP) directed restricted expression only in neurons and glia and not NSC, recapitulating the endogenous expression pattern required to avoid detrimental consequences of MECP2 ectopic expression. In differentiated NSC from adult heterozygous Mecp2(tm1.1Bird)+/- female mice, 48% of neurons expressed endogenous MeCP2 due to random inactivation of the X-linked Mecp2 gene. Retroviral MECP2 transduction with EF1alpha and MeP vectors rescued expression in 95-100% of neurons resulting in increased dendrite branching function in vitro. Insulated MECP2 isoform-specific lentiviral vectors show long-term expression in NSC and their differentiated neuronal progeny, and directly infect dissociated murine cortical neurons with high efficiency. CONCLUSIONS/SIGNIFICANCE: MeP vectors recapitulate the endogenous expression pattern of MeCP2 in neurons and glia. They have utility to study MeCP2 isoform-specific functions in vitro, and are effective gene therapy vectors for rescuing dendritic maturation of neurons in an ex vivo model of RTT.


Subject(s)
Gene Expression Regulation , Genetic Therapy , Genetic Vectors , Methyl-CpG-Binding Protein 2/genetics , Rett Syndrome/therapy , Animals , Female , Humans , Lentivirus/genetics , Mice , Promoter Regions, Genetic , Transduction, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL